Continuous ranibizumab via port delivery system vs monthly ranibizumab for treatment of diabetic macular edema: the pagoda randomized clinical trial
Khanani AM, Campochiaro PA, Graff JM, et al.
JAMA Ophthalmol. 2025:e250006.
Leggi
Breaking news
Port delivery system with ranibizumab vs monitoring in nonproliferative diabetic retinopathy without macular edema: the pavilion randomized clinical trial
Pieramici DJ, Awh CC, Chang M, et al.
JAMA Ophthalmol. 2025:e250001.
Leggi
Differential effects of type 2 diabetes and gestational diabetes on maternal and cord blood adipokines and newborn weight
Gruber BL, Rawal Y, Irabor P, et al.
BMC Pregnancy Childbirth. 2025;25(1):238.
Leggi
Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: a target trial emulation study
Ju C, Xiong X, Lui DTW, et al.
Diabetes Res Clin Pract. 2025:112082.
Leggi
Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes
Tsoi AT, Sng J, Tummanapalli SS, et al.
Diabetologia. Pub. online 7 Mar 2025.
Leggi
The impact of sodium-glucose cotransporter-2 inhibitors on atrial fibrillation burden in diabetic patients
Kidess GG, Hamza M, Goru R, et al.
Am J Cardiol. Pub. online 7 Mar 2025.
Leggi
Multivitamins after myocardial infarction in patients with diabetes: a randomized clinical trial
Ujueta F, Lamas GA, Anstrom KJ, et al.
JAMA Intern Med. 2025:e248408.
Leggi
AIFA: Una App a semaforo targata AIFA per favorire l’uso appropriato degli antibiotici
04/03/2025
Leggi
Continuous glucose monitoring-based titration of once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes (ONWARDS 9): a phase 3b, multicenter, single-arm, treat-to-target clinical trial
Bergenstal RM, Ásbjörnsdóttir B, Johanning Bari T, et al.
Diabetes Technol Ther. Pub. online 5 Mar 2025.
Leggi